Severe Hantavirus Disease Associated with Low Serum TGF-β Levels
By LabMedica International staff writers Posted on 27 Apr 2015 |
Image: Transmission electron micrograph of Puumala virus (Photo courtesy of Hans R. Gelderblom and Freya Kaulbars).
Hantaviruses are emerging zoonotic pathogens which cause hemorrhagic fever with renal syndrome, an immune-mediated pathogenesis, and the role of transforming growth factor-β (TGF-β) expression in acute Hantavirus infection has been investigated.
TGF-β has a pivotal function in the immune system and controls the initiation and resolution of inflammatory responses through the regulation of chemotaxis, activation, and survival of lymphocytes, natural killer cells, dendritic cells, macrophages, mast cells, and granulocytes.
Scientists at the University of Heidelberg (Germany) and their colleagues retrospectively studied 77 patients hospitalized with acute Puumala virus infection during a Hantavirus epidemic in Germany in 2012. The mean age of patients was 40.8 years, 52 were male (68%), five (6%) were under the age of 18 years. Polymerase chain reaction (PCR) for the detection of Hantavirus ribonucleic acid (RNA) was performed on the L-segment.
Sera were tested for Hantavirus immunoglobulin G (IgG) and IgM antibodies using the recomLine Hantavirus assay (Mikrogen; Munich, Germany), coated with specific Hantavirus nucleocapsid antigens of Puumala virus, Dobrava-Belgrade virus, Hantaan virus, and Seoul virus. TGF-β1, β2 and β3 were measured with the Luminex TGF assay (R&D Systems, Wiesbaden, Germany). All cytokines, neopterin and C-reactive protein (CRP) were determined on admission of the patients to the hospital and one week after admission.
Puumala virus RNA was detectable in 4/77 cases. Patients with severe disease had a significant longer hospital stay than patients with mild disease (6.2 days versus 3.6 days). Thrombocyte count 186/nL versus 225/nL), serum TGF-β1 (74 ng/L versus 118 ng/L) and TGF-β2 (479 pg/L versus 586 pg/L) were significantly lower in severe compared to mild disease. However, CRP was significantly higher in patients with severe disease (62 mg/L versus 40 mg/L). TGF-β1/Cr ratio was the most sensitive and specific marker associated with renal dysfunction.
The authors concluded that measurement of TGF-βs and especially TGF-βs/Cr ratios in the early phase of Puumala Hantavirus infection are very sensitive markers of kidney damage and that high expression of TGF-β1 and TGF-β2 are associated with milder courses of Hantavirus infection. High CRP is a marker of disease severity in Hantavirus infection. The results support the hypothesis of an immune-mediated pathogenesis of Hantavirus infection. The study was published on April 14, 2015, in the journal BMC Immunology.
Related Links:
University of Heidelberg
Mikrogen
R&D Systems
TGF-β has a pivotal function in the immune system and controls the initiation and resolution of inflammatory responses through the regulation of chemotaxis, activation, and survival of lymphocytes, natural killer cells, dendritic cells, macrophages, mast cells, and granulocytes.
Scientists at the University of Heidelberg (Germany) and their colleagues retrospectively studied 77 patients hospitalized with acute Puumala virus infection during a Hantavirus epidemic in Germany in 2012. The mean age of patients was 40.8 years, 52 were male (68%), five (6%) were under the age of 18 years. Polymerase chain reaction (PCR) for the detection of Hantavirus ribonucleic acid (RNA) was performed on the L-segment.
Sera were tested for Hantavirus immunoglobulin G (IgG) and IgM antibodies using the recomLine Hantavirus assay (Mikrogen; Munich, Germany), coated with specific Hantavirus nucleocapsid antigens of Puumala virus, Dobrava-Belgrade virus, Hantaan virus, and Seoul virus. TGF-β1, β2 and β3 were measured with the Luminex TGF assay (R&D Systems, Wiesbaden, Germany). All cytokines, neopterin and C-reactive protein (CRP) were determined on admission of the patients to the hospital and one week after admission.
Puumala virus RNA was detectable in 4/77 cases. Patients with severe disease had a significant longer hospital stay than patients with mild disease (6.2 days versus 3.6 days). Thrombocyte count 186/nL versus 225/nL), serum TGF-β1 (74 ng/L versus 118 ng/L) and TGF-β2 (479 pg/L versus 586 pg/L) were significantly lower in severe compared to mild disease. However, CRP was significantly higher in patients with severe disease (62 mg/L versus 40 mg/L). TGF-β1/Cr ratio was the most sensitive and specific marker associated with renal dysfunction.
The authors concluded that measurement of TGF-βs and especially TGF-βs/Cr ratios in the early phase of Puumala Hantavirus infection are very sensitive markers of kidney damage and that high expression of TGF-β1 and TGF-β2 are associated with milder courses of Hantavirus infection. High CRP is a marker of disease severity in Hantavirus infection. The results support the hypothesis of an immune-mediated pathogenesis of Hantavirus infection. The study was published on April 14, 2015, in the journal BMC Immunology.
Related Links:
University of Heidelberg
Mikrogen
R&D Systems
Latest Immunology News
- AI Predicts Tumor-Killing Cells with High Accuracy
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form